The Clinical Audit in Pharmaceutical Development / Edition 1

Hardcover (Print)
Used and New from Other Sellers
Used and New from Other Sellers
from $19.80
Usually ships in 1-2 business days
(Save 87%)
Other sellers (Hardcover)
  • All (4) from $19.80   
  • New (1) from $248.92   
  • Used (3) from $19.80   
Close
Sort by
Page 1 of 1
Showing All
Note: Marketplace items are not eligible for any BN.com coupons and promotions
$248.92
Seller since 2011

Feedback rating:

(865)

Condition:

New — never opened or used in original packaging.

Like New — packaging may have been opened. A "Like New" item is suitable to give as a gift.

Very Good — may have minor signs of wear on packaging but item works perfectly and has no damage.

Good — item is in good condition but packaging may have signs of shelf wear/aging or torn packaging. All specific defects should be noted in the Comments section associated with each item.

Acceptable — item is in working order but may show signs of wear such as scratches or torn packaging. All specific defects should be noted in the Comments section associated with each item.

Used — An item that has been opened and may show signs of wear. All specific defects should be noted in the Comments section associated with each item.

Refurbished — A used item that has been renewed or updated and verified to be in proper working condition. Not necessarily completed by the original manufacturer.

New
Brand new and unread! Join our growing list of satisfied customers!

Ships from: Phoenix, MD

Usually ships in 1-2 business days

  • Standard, 48 States
  • Standard (AK, HI)
Page 1 of 1
Showing All
Close
Sort by

Overview

This blue-chip guide adds quality to the pharmaceutical clinical development process by detailing the need for, and stressing the importance of, an independent audit of clinical data to protect participants and validate study results.
Examines the use of personal computers, the Internet, and third-party organizations to assist in data validation!
Positioning the audit as the only reliable tool to verify that a drug has been shown to be safe and effective in clinical trials, The Clinical Audit in Pharmaceutical Development

  • recommends establishing auditing and quality assurance at the beginning of a clinical study
  • describes Good Clinical Practices (GCPs) and the role of regulatory agencies in the review, validation, and auditing processes
  • outlines the clinical process, from trial design through report writing
  • compares and contrasts United States and international regulatory statutes
  • identifies monitoring as the key to guaranteeing high-quality data
  • focuses on the role of the clinical audit in achieving unity in a multinational study
  • discusses the worldwide influence of the US Food and Drug Administration audit
  • analyzes findings from previous FDA clinical audits to reveal trends and future directions
  • provides guidelines for fraud detection and considers the ramifications of falsified data
  • and more!
    Confirming that all clinical information has been properly collected and reported, The Clinical Audit in Pharmaceutical Development is a crucial reference for clinical and research pharmacists and pharmacologists; biostatisticians; clinical research associates, coordinators, and investigators; quality control, quality assurance, and regulatory compliance managers; and upper-level undergraduate and graduate students in these disciplines.

The book contains black-and-white illustrations.

Read More Show Less

Editorial Reviews

Doody's Review Service
Reviewer: Cheryl Lynn Nunn-Thompson, PharmD, MBA (University of Illinois at Chicago College of Pharmacy)
Description: This book is a review of global efforts by regulatory agencies and clinical study sponsors to validate and audit clinical study data. Contributors also provide a comprehensive overview of management of quality assurance in clinical trials, Good Clinical Practices (GCP), and management of audit outcomes.
Purpose: According to the editor, the purpose is to "gather the collective expertise of a worldwide group of experts to address the current issues and trends in the validation and auditing or a clinical study." These are worthy objectives, as quality issues in the drug approval process encompass international challenges to build quality assurance into the design of clinical trials. In particular, this is an important book given recent disclosures regarding fraud and misconduct in clinical research; the audit of clinical trial data is important to avoid this problem in future research. The editor has achieved his stated purpose/objectives.
Audience: Although the editor does not specify an audience for this text, it would be suitable for a wide range of individuals involved in either designing or auditing clinical trial data. This would include quality assurance personnel in the pharmaceutical industry or in governmental regulatory agencies, individuals from contract research organizations (CRO), members of institutional review boards (IRB) committees, or clinical investigators. The editor of the text is a consultant in this field; chapters are written by eleven contributors whose expertise appears to be related to the field of quality assurance of clinical trial data. Unfortunately, biographies of these individuals are not provided for the reader.
Features: Overviews of the clinical development process, statutory requirements and regulatory guidance, clinical auditors' observations, quality assurance in clinical trials, standardizing quality in clinical trials, GCP, and computers, Food and Drug Administration (FDA) audits, international assessment of GCP compliance, and fraud in clinical research are all provided in this book. Each chapter contributor provides a general overview of the topic and refers readers to additional sources for more comprehensive and technical information. Each chapter is fairly current in content and minimally referenced; this book does not contain any graphics or tables. An appendix contains a several reference documents.
Assessment: This would be a useful introductory text for individuals involved in the validation and auditing of clinical trial information. The editor provides an international perspective on designing quality into clinical research, covers important sub-topics in the field, and presents the information at a general level.
Cheryl Lynn Nunn-Thompson
This book is a review of global efforts by regulatory agencies and clinical study sponsors to validate and audit clinical study data. Contributors also provide a comprehensive overview of management of quality assurance in clinical trials, Good Clinical Practices (GCP), and management of audit outcomes. According to the editor, the purpose is to ""gather the collective expertise of a worldwide group of experts to address the current issues and trends in the validation and auditing or a clinical study."" These are worthy objectives, as quality issues in the drug approval process encompass international challenges to build quality assurance into the design of clinical trials. In particular, this is an important book given recent disclosures regarding fraud and misconduct in clinical research; the audit of clinical trial data is important to avoid this problem in future research. The editor has achieved his stated purpose/objectives. Although the editor does not specify an audience for this text, it would be suitable for a wide range of individuals involved in either designing or auditing clinical trial data. This would include quality assurance personnel in the pharmaceutical industry or in governmental regulatory agencies, individuals from contract research organizations (CRO), members of institutional review boards (IRB) committees, or clinical investigators. The editor of the text is a consultant in this field; chapters are written by eleven contributors whose expertise appears to be related to the field of quality assurance of clinical trial data. Unfortunately, biographies of these individuals are not provided for the reader. Overviews of the clinical development process,statutory requirements and regulatory guidance, clinical auditors' observations, quality assurance in clinical trials, standardizing quality in clinical trials, GCP, and computers, Food and Drug Administration (FDA) audits, international assessment of GCP compliance, and fraud in clinical research are all provided in this book. Each chapter contributor provides a general overview of the topic and refers readers to additional sources for more comprehensive and technical information. Each chapter is fairly current in content and minimally referenced; this book does not contain any graphics or tables. An appendix contains a several reference documents. This would be a useful introductory text for individuals involved in the validation and auditing of clinical trial information. The editor provides an international perspective on designing quality into clinical research, covers important sub-topics in the field, and presents the information at a general level.
Booknews
This collection of articles stresses the need and importance of an independent audit of clinical data in the pharmaceutical clinical development process. Specialists and administrators in the pharmaceuticals industry recommend introducing auditing and quality assurance at the beginning of a clinical study; outline the clinical process; compare the United States to international regulatory statutes; discuss a variety of approaches such as using personal computers, the Internet, and third-party organizations to assist in data validation; provide guidelines for fraud detection; and deliberate about the consequences of falsified data. Annotation c. Book News, Inc., Portland, OR (booknews.com)

3 Stars from Doody
Read More Show Less

Product Details

  • ISBN-13: 9780824703097
  • Publisher: Taylor & Francis
  • Publication date: 11/28/1999
  • Series: Drugs and the Pharmaceutical Sciences Series
  • Edition description: New Edition
  • Edition number: 1
  • Pages: 224
  • Product dimensions: 6.25 (w) x 9.25 (h) x 1.00 (d)

Table of Contents

Introduction to the Clinical Development Process
Michael R. Hamrell
Statutory Requirements and Regulatory Guidance
Tammala Woodrum, Diana B. Lee, and Jon R. Wallace
Source Documentation: Clinical Auditors' Observations
Vernette J. Molloy and Douglas R. Mackintosh
Quality Assurance in Clinical Trials
Richard Kiernan
Standardizing Quality in International Studies
Marijke Korteweg
Good Clinical Practices and Computers
Tammala Woodrum
Food and Drug Administration Audit
Arthur M. Horowitz
GCP Compliance Assessed by Independent Auditing: International Similarities and Difference
W. Boyachuk and G. Ball
Fraud and Misconduct in Clinical Research
Frank Wells

Appendix: ENGAGE: European Network of GCP Auditors and Other GCP Experts

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)